Healthcare - Biotechnology - NASDAQ - US
$ 0.46
2.68 %
$ 43.4 M
Market Cap
-1.35
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
390.83%
EBIT
Estimate
55.00%
Net Income
Estimate
27.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Unicycive Therapeutics, Inc.
UNCY has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart UNCY
EBIT FORECAST
EBIT Forecast Chart UNCY
NET INCOME FORECAST
Net Income Chart UNCY